Skip to content

Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products - Arizona, June-October 2024.

Heather L. Walker, Maureen Roland, Steven Dudley, Kenneth Komatsu, Joli Weiss, Jamaica Dillard, Hsin-I Lin, Laura Rust, Traci Plummer, Rachel Berg, Stephen Everett, Arthur Chang, Michael Yeh, Johnni Daniel, Shane Brady

MMWR Morbidity and Mortality Weekly Report January 9, 2025 DOI: 10.15585/mmwr.mm7401a3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Outbreak report Peer reviewed
Intervention gummies
Topics Microdosing
Citations 1
Key points A national outbreak of illness was associated with ingestion of Diamond Shruumz-brand products sold as chocolate bars, gummies, and cones. The report notes that similar products containing psychoactive compounds are increasingly available, with some known to contain unlabeled psychoactive substances.

Abstract

In June 2024, Arizona Department of Health Services (ADHS) was notified by Arizona's poison control centers (PCCs)* of adverse health outcomes occurring after ingestion of a Diamond Shruumz-brand product containing proprietary blends of mushroom extracts and adaptogens.† These products were sold as chocolate bars, gummies, and cones and could be purchased online or at local retailers nationwide.§ Availability of similar products containing psychoactive compounds is increasing, with some known to contain unlabeled psychoactive substances (1,2).This report describes findings from a national outbreak of illness associated with ingestion of Diamond Shruumz-brand products.This activity was reviewed by CDC, deemed not research, and was conducted consistent with applicable federal law and CDC policy.

Citations in the library

Explore topics